Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Luciana Gavernet is active.

Publication


Featured researches published by Luciana Gavernet.


Chemical Biology & Drug Design | 2011

Synthesis of 2-Hydrazolyl-4-Thiazolidinones Based on Multicomponent Reactions and Biological Evaluation Against Trypanosoma Cruzi

Chiara Pizzo; Cecilia Saiz; Alan Talevi; Luciana Gavernet; Pablo H. Palestro; Carolina L. Bellera; Luis Bruno Blanch; Diego Benítez; Juan José Cazzulo; Agustina Chidichimo; Peter Wipf; S. Graciela Mahler

A series of 18 novel 2‐hydrazolyl‐4‐thiazolidinones‐5‐carboxylic acids, amides and 5,6‐α,β‐unsaturated esters were synthesized, and their in vitro activity on cruzipain and T. cruzi epimastigotes was determined. Some agents show activity at 37 μm concentration in the enzyme assay. Computational tools and docking were used to correlate the biological response with the physicochemical parameters of the compounds and their cruzipain inhibitory effects.


European Journal of Medicinal Chemistry | 2015

Computer-guided drug repurposing: Identification of trypanocidal activity of clofazimine, benidipine and saquinavir

Carolina L. Bellera; Darío E. Balcazar; M. Cristina Vanrell; A. Florencia Casassa; Pablo H. Palestro; Luciana Gavernet; Carlos Alberto Labriola; Jorge Gálvez; Luis E. Bruno-Blanch; Patricia S. Romano; Carolina Carrillo; Alan Talevi

In spite of remarkable advances in the knowledge on Trypanosoma cruzi biology, no medications to treat Chagas disease have been approved in the last 40 years and almost 8 million people remain infected. Since the public sector and non-profit organizations play a significant role in the research efforts on Chagas disease, it is important to implement research strategies that promote translation of basic research into the clinical practice. Recent international public-private initiatives address the potential of drug repositioning (i.e. finding second or further medical uses for known-medications) which can substantially improve the success at clinical trials and the innovation in the pharmaceutical field. In this work, we present the computer-aided identification of approved drugs clofazimine, benidipine and saquinavir as potential trypanocidal compounds and test their effects at biochemical as much as cellular level on different parasite stages. According to the obtained results, we discuss biopharmaceutical, toxicological and physiopathological criteria applied to decide to move clofazimine and benidipine into preclinical phase, in an acute model of infection. The article illustrates the potential of computer-guided drug repositioning to integrate and optimize drug discovery and preclinical development; it also proposes rational rules to select which among repositioned candidates should advance to investigational drug status and offers a new insight on clofazimine and benidipine as candidate treatments for Chagas disease. One Sentence Summary: We present the computer-guided drug repositioning of three approved drugs as potential new treatments for Chagas disease, integrating computer-aided drug screening and biochemical, cellular and preclinical tests.


Current Computer - Aided Drug Design | 2009

Combined Virtual Screening Strategies

Alan Talevi; Luciana Gavernet; Luis E. Bruno-Blanch

The progress in chemical knowledge and synthetic technologies over the last fifty-years has dramatically increased the synthetic accessible chemical entities. Exploration of natural products rich chemodiversity has also expanded the vast chemical universe where medicinal chemist can pursue the identification of new therapeutic agents. Virtual Screening (VS) benefits from computational technology to explore the increasingly vast chemical universe in an efficient manner. The different VS approaches may be characterized by the computational and human time they require, from the highly automated and fast 2D-QSAR ligand-based VS to the more demanding 3D QSAR and target-based (docking) methodologies. Recently, several studies based on the integration of different VS approaches have been proposed, demonstrating that the hit recovery rate may be maintained (or even increased) with a substantial reduction of computing times. Combined virtual screening methodologies usually begin with the least-demanding approaches at the beginning of the VS process and progress to the more accurate, time consuming techniques in the last stages. This review discusses recent 2D/3D QSAR and ligand-based/target-based “synergistic” combinations that allow speeding-up the VS process, permitting accurate and efficient studies on large databases. The impact of the combination of different techniques on the chemical diversity of the compounds retrieved is also discussed.


Journal of Molecular Structure-theochem | 2000

Maximum topological distances based indices as molecular descriptors for QSPR. Part 1. Application to alkyl benzenes boiling points

M Firpo; Luciana Gavernet; Eduardo A. Castro; Andrey A. Toropov

Abstract Several topological indices based upon maximum matrix distance are employed, in order to analyse their use in predicting boiling points of a representative set of alkyl benzene molecules. The results are quite satisfactory and they improve upon previous ones obtained via the standard topological matrix distance. Higher order relationships prove to be very good, when compared to the usual linear ones, in getting excellent predictions.


BioMed Research International | 2014

Docking Applied to the Prediction of the Affinity of Compounds to P-Glycoprotein

Pablo H. Palestro; Luciana Gavernet; Guillermina Estiu; Luis Bruno Blanch

P-glycoprotein (P-gp) is involved in the transport of xenobiotic compounds and responsible for the decrease of the drug accumulation in multi-drug-resistant cells. In this investigation we compare several docking algorithms in order to find the conditions that are able to discriminate between P-gp binders and nonbinders. We built a comprehensive dataset of binders and nonbinders based on a careful analysis of the experimental data available in the literature, trying to overcome the discrepancy noticeable in the experimental results. We found that Autodock Vina flexible docking is the best choice for the tested options. The results will be useful to filter virtual screening results in the rational design of new drugs that are not expected to be expelled by P-gp.


Bioorganic & Medicinal Chemistry | 2013

Inhibition pattern of sulfamide-related compounds in binding to carbonic anhydrase isoforms I, II, VII, XII and XIV.

Luciana Gavernet; Jose L. Gonzalez Funes; Pablo H. Palestro; Luis Bruno Blanch; Guillermina Estiu; Alfonso Maresca; Ivana Barrios; Claudiu T. Supuran

A set of sulfamides and sulfamates were synthesized and tested against several isoforms of carbonic anhydrase: CA I, CA II, CA VII, CA XII and CA XIV. The biological assays showed a broad range of inhibitory activity, and interesting results were found for several compounds in terms of activity (Ki <1μm) and selectivity: some aromatic sulfamides are active against CA I, CA II and/or CA VII; while they are less active in CA XII and CA XIV. On the other hand, bulky sulfamides are selective to CA VII. To understand the origin of the different inhibitory activity against each isozyme we used molecular modeling techniques such as docking and molecular dynamic simulations.


Journal of Chemical Information and Modeling | 2010

Affinity of sulfamates and sulfamides to carbonic anhydrase II isoform: experimental and molecular modeling approaches.

Luciana Gavernet; Jose L. Gonzalez Funes; Luis Bruno Blanch; Guillermina Estiu; Alfonso Maresca; Claudiu T. Supuran

Sixteen aromatic and aliphatic sulfamides and sulfamates were synthesized and tested in their inhibition to carbonic anhydrase CAII activity. The weaker inhibition pattern shown by sulfamides as compared to sulfamates is interpreted in this research by means of molecular modeling techniques, including known inhibitors (topiramate and its sulfamide cognate) in the analysis. The results nicely explain the origin of the inhibitory activity, which is not only related to positive interactions of the ligand with the active site residues but also to the solvation pattern characteristic of each ligand.


Journal of Medicinal Chemistry | 2009

Synthesis and Anticonvulsant Activity of Amino Acid-Derived Sulfamides

Luciana Gavernet; Juan E. Elvira; Gisela Samaja; Valentina Pastore; Mariana Sella Cravero; Andrea V. Enrique; Guillermina Estiu; Luis E. Bruno-Blanch

Sulfamides are promising functions for the design of new antiepileptic drugs ( Bioorg. Med. Chem. 2007, 15, 1556-1567; 5604-5614 ). Following previous research in this line, a set of amino acid-derived sulfamides has been designed, synthesized, and tested as new anticonvulsant compounds. The experimental data confirmed the ability of some of the structures to suppress the convulsions originated by the electrical seizure (MES test) at low doses (100 mg/kg).


Journal of Molecular Structure-theochem | 2000

Spectrometric and theoretical evidences for the occurrence of tautomeric structures of selected ketones

Patricia E. Allegretti; Luciana Gavernet; Eduardo A. Castro; Jorge J. P. Furlong

Abstract The enolisation degree of ketones is generally favoured by the increase of the steric effect exerted by the substitution α to the carbonyl group. The analysis of the corresponding mass spectra has allowed us to assign unambiguously some fragmentations to specific tautomers and to establish an acceptable correlation between the corresponding ion abundance ratios and the AM1 MO theoretical calculation of the approximate enolisation equilibrium constants.


Journal of Chemical Information and Modeling | 2012

Several New Diverse Anticonvulsant Agents Discovered in a Virtual Screening Campaign Aimed at Novel Antiepileptic Drugs to Treat Refractory Epilepsy

Mauricio E. Di Ianni; Andrea V. Enrique; Pablo H. Palestro; Luciana Gavernet; Alan Talevi; Luis E. Bruno-Blanch

A virtual screening campaign was conducted in order to discover new anticonvulsant drug candidates for the treatment of refractory epilepsy. To this purpose, a topological discriminant function to identify antiMES drugs and a sequential filtering methodology to discriminate P-glycoprotein substrates and nonsubstrates were jointly applied to ZINC 5 and DrugBank databases. The virtual filters combine an ensemble of 2D classifiers and docking simulations. In the light of the results, 10 structurally diverse compounds were acquired and tested in animal models of seizure and the rotorod test. All 10 candidates showed some level of protection against MES test.

Collaboration


Dive into the Luciana Gavernet's collaboration.

Top Co-Authors

Avatar

Luis E. Bruno-Blanch

National University of La Plata

View shared research outputs
Top Co-Authors

Avatar

Pablo H. Palestro

National University of La Plata

View shared research outputs
Top Co-Authors

Avatar

Alan Talevi

National University of La Plata

View shared research outputs
Top Co-Authors

Avatar

Luis Bruno Blanch

National University of La Plata

View shared research outputs
Top Co-Authors

Avatar

Eduardo A. Castro

National Scientific and Technical Research Council

View shared research outputs
Top Co-Authors

Avatar

María Luisa Villalba

National University of La Plata

View shared research outputs
Top Co-Authors

Avatar

Andrea V. Enrique

National University of La Plata

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Ileana D. Lick

National University of La Plata

View shared research outputs
Top Co-Authors

Avatar

Ivana Barrios

National University of La Plata

View shared research outputs
Researchain Logo
Decentralizing Knowledge